Nothing Special   »   [go: up one dir, main page]

AU2002215982A1 - Topical treatment of mastalgia with arometese inhibitors such as androstendione - Google Patents

Topical treatment of mastalgia with arometese inhibitors such as androstendione

Info

Publication number
AU2002215982A1
AU2002215982A1 AU2002215982A AU1598202A AU2002215982A1 AU 2002215982 A1 AU2002215982 A1 AU 2002215982A1 AU 2002215982 A AU2002215982 A AU 2002215982A AU 1598202 A AU1598202 A AU 1598202A AU 2002215982 A1 AU2002215982 A1 AU 2002215982A1
Authority
AU
Australia
Prior art keywords
mastalgia
arometese
androstendione
inhibitors
topical treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002215982A
Inventor
Alfred Schmidt
Heinrich Wieland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2002215982(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU2002215982A1 publication Critical patent/AU2002215982A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Massaging Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A composition for medicinal treatment by means of topical administration is described, which contains an aromatase inhibitor, in addition to conventional constituents of topical forms of administration. The active ingredient or the composition containing this active ingredient is especially suitable for the prophylaxis and for the treatment of mastalgia.
AU2002215982A 2000-11-02 2001-10-30 Topical treatment of mastalgia with arometese inhibitors such as androstendione Abandoned AU2002215982A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054294.8 2000-11-02
DE10054294A DE10054294A1 (en) 2000-11-02 2000-11-02 Topical treatment for mastalgia
PCT/EP2001/012536 WO2002036129A2 (en) 2000-11-02 2001-10-30 Topical treatment of mastalgia with arometese inhibitors such as androstendione

Publications (1)

Publication Number Publication Date
AU2002215982A1 true AU2002215982A1 (en) 2002-05-15

Family

ID=7661891

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002215982A Abandoned AU2002215982A1 (en) 2000-11-02 2001-10-30 Topical treatment of mastalgia with arometese inhibitors such as androstendione

Country Status (10)

Country Link
US (1) US20040018991A1 (en)
EP (1) EP1414467B1 (en)
AT (1) ATE324112T1 (en)
AU (1) AU2002215982A1 (en)
CY (1) CY1106319T1 (en)
DE (2) DE10054294A1 (en)
DK (1) DK1414467T3 (en)
ES (1) ES2263682T3 (en)
PT (1) PT1414467E (en)
WO (1) WO2002036129A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022342D0 (en) 2000-09-12 2000-10-25 Creative Peptides Sweden Ab Reduction of the electrocardiographic QT interval
PL370889A1 (en) 2001-12-20 2005-05-30 Femmepharma, Inc. Vaginal delivery of drugs
PT1572178E (en) * 2002-12-18 2006-09-29 Besins Int Lab TREATMENT OF MASTALGIA WITH 4-HYDROXY-TAMOXYPHEN
EP1578421A4 (en) * 2003-01-02 2009-04-22 Femmepharma Holding Co Inc Pharmaceutical preparations for treatments of diseases and disorders of the breast
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1854465A1 (en) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
EP1875908A1 (en) * 2006-07-05 2008-01-09 Johannes Huber Use of Chrysin
WO2008019048A1 (en) * 2006-08-04 2008-02-14 Meditrina Pharmaceuticals Use of aromatase inhibitors for thining the endometrium or treating menorrhagia
CA2674078C (en) * 2006-12-26 2012-03-20 Femmepharma Holding Company, Inc. Topical administration of danazol
WO2008115413A1 (en) * 2007-03-16 2008-09-25 Meditrina Pharmaceuticals, Inc. Aromatase inhibitors for the treatment of mastalgia
US20100292150A1 (en) * 2007-12-10 2010-11-18 Meditrina Pharmaceuticals, Inc. Treatment of Menorrhagia with Aromatase Inhibitor
DE102008012988A1 (en) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Composition and uses for influencing hair growth
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
WO2012104241A1 (en) 2011-01-31 2012-08-09 LUCOLAS-M.D. Ltd Combinations of aromatase inhibitors and antioxidants

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (en) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre ANTI-ESTROGEN MEDICINAL PRODUCT BASED ON 4-HYDROXYTAMOXIFENE FOR PERCUTANEOUS ADMINISTRATION
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
EP0342665A3 (en) * 1988-05-20 1990-08-16 Takeda Chemical Industries, Ltd. Physiologically active substance tan-931, its derivatives, their production and use
AU1893492A (en) * 1991-04-17 1992-11-17 Merck & Co., Inc. Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
FR2677027B1 (en) * 1991-05-27 1993-09-10 Roussel Uclaf NEW STEROUID PRODUCTS SUBSTITUTED IN POSITION 6, AND COMPRISING, IN POSITION 10, A THIOETHYL RADICAL, THEIR PROCESS FOR THE PREPARATION OF THEIR INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS.
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
CA2150326A1 (en) * 1994-05-27 1995-11-28 Kimihiro Murakami Azolyl methyl phenyl derivatives having aromatase inhibitory activity
ATE197889T1 (en) * 1994-09-14 2000-12-15 Univ Sheffield CONTROL HAIR GROWTH
WO1997036570A1 (en) * 1996-03-29 1997-10-09 S.W. Patentverwertungs Ges. M.B.H. Edelsbacher U. Partner Cosmetic or cosmetic preparation for smoothing and tightening the skin in the case of subcutaneous fatty tissue problems, particularly cellulite
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US5906987A (en) * 1997-03-10 1999-05-25 Schering Aktiengesellschaft And Board Of Regents Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
EP0943333A1 (en) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6638727B1 (en) * 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
WO2001012206A2 (en) * 1999-08-13 2001-02-22 Heinrich Wieland Soy-glycine extracts and aromatase inhibitors for positively influencing collagen

Also Published As

Publication number Publication date
DE50109650D1 (en) 2006-06-01
DE10054294A1 (en) 2002-05-16
PT1414467E (en) 2006-09-29
ATE324112T1 (en) 2006-05-15
US20040018991A1 (en) 2004-01-29
WO2002036129A2 (en) 2002-05-10
CY1106319T1 (en) 2011-10-12
ES2263682T3 (en) 2006-12-16
DK1414467T3 (en) 2006-08-28
WO2002036129A3 (en) 2004-02-26
EP1414467A2 (en) 2004-05-06
EP1414467B1 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
AU2002215982A1 (en) Topical treatment of mastalgia with arometese inhibitors such as androstendione
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
IL158559A (en) Use of 5-lipoxygenase inhibitors for the preparation of a pharmaceutical composition for treating acne
HUP0301405A2 (en) Compositions containing therapeutically active components having enhanced solubility
MY143795A (en) Tetrahydropyridoindole derivatives
MX2007006539A (en) System for improved percutaneous absorption of skin benefiting agents.
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
AU2931500A (en) Pharmaceutical composition containing nitrate source and an acidifying agent fortreating skin ischaemia
CA2408142A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200514772A (en) Novel tetrahydropyridine derivatives
NO20055766L (en) Positive modulators of nicotine acetylcholine receptors
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
WO2004052308A3 (en) Topical anti-infective formulations
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200621773A (en) Bicyclononene derivatives
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
TW200628468A (en) Bicyclononene derivatives
AU2001261516A1 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2003035080A3 (en) A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
NO20073575L (en) Pharmaceutical compositions for the treatment of cellulite
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1